Cloverleaf Bio

New Haven biotech raises $33M for cancer drug development

Cloverleaf Bio will use the funding to move its RNA-based liver cancer treatment into early-stage human testing.
ADVERTISEMENT

Latest Stories

More Business News

Thought Leadership

More Thought Leadership
ADVERTISEMENT

Movers & Shakers

More Movers & Shakers | Submit Movers & Shakers

Business Announcements

More Announcements | Submit Business Announcements
More Events | Submit an Event